ICL Notícias - Jornalismo Independente [Unofficial]Estudantes de medicina são cooptados para contrabandear canetas paraguaias
https://fed.brid.gy/r/https://iclnoticias.com.br/estudantes-medicina-contrabando-canetas/
≡ʀʀ🇵🇱
Howard Smith MD, AMWhy Those Taking Weight Loss Pills Stop Losing Weight. The reason is in your brain cells. References on my website. #Ozempic #Wegovy #WeightLossResearch #GLP1 #HealthyAging
https://www.instagram.com/p/DZLLmxzpLFP/
https://www.instagram.com/p/DZLLmxzpLFP/
Howard G. Smith MD, AM on Instagram: "Why Those Taking Weight Loss Pills Stop Losing Weight You’re getting those weight loss shots. You’re delighted as you lose weight for months. Then those scale numbers suddenly stops moving in the right direction. Why? NIH endocrinologists now show that the answer appears to be hiding inside your brain cells. They find that semaglutide, the active ingredient in Ozempic and Wegovy, triggers variable responses in appetite-controlling brain cells. That seems to be why some people lose more weight than others and why weight loss often plateaus over time. Their studies of brain tissue in mice show that semaglutide boosts a signaling molecule called cAMP inside neurons that helps regulate your appetite. But not all brain cells respond the same way. Some maintain the signal for longer periods, while others appeared to shut down their responses more quickly. When they do, the appetite-suppressing effects weaken and contribute to the weight-loss plateau that many patients experience. This finding suggests a possible way to prolong the drug’s effects. By blocking an enzyme called PDE4 with a medication known as roflumilast, the investigators were able to extend the cAMP signal in more neurons. While this finding was observed only in mice and has not been confirmed in people, it raises the possibility that future treatments could help you continue losing weight and maintain that ideal weight for longer periods of time. The references for this report are available on my website. #Ozempic #Wegovy #WeightLossResearch #GLP1 #HealthyAging"
0 likes, 0 comments - drhowardsmithreports on June 4, 2026: "Why Those Taking Weight Loss Pills Stop Losing Weight You’re getting those weight loss shots. You’re delighted as you lose weight for months. Then those scale numbers suddenly stops moving in the right direction. Why? NIH endocrinologists now show that the answer appears to be hiding inside your brain cells. They find that semaglutide, the active ingredient in Ozempic and Wegovy, triggers variable responses in appetite-controlling brain cells. That seems to be why some people lose more weight than others and why weight loss often plateaus over time. Their studies of brain tissue in mice show that semaglutide boosts a signaling molecule called cAMP inside neurons that helps regulate your appetite. But not all brain cells respond the same way. Some maintain the signal for longer periods, while others appeared to shut down their responses more quickly. When they do, the appetite-suppressing effects weaken and contribute to the weight-loss plateau that many patients experience. This finding suggests a possible way to prolong the drug’s effects. By blocking an enzyme called PDE4 with a medication known as roflumilast, the investigators were able to extend the cAMP signal in more neurons. While this finding was observed only in mice and has not been confirmed in people, it raises the possibility that future treatments could help you continue losing weight and maintain that ideal weight for longer periods of time. The references for this report are available on my website. #Ozempic #Wegovy #WeightLossResearch #GLP1 #HealthyAging".
Futuro Prossimo 
Una pillola che fa quello che farebbe la palestra: brucia grasso, alza il metabolismo, ma soprattutto non ti porta via il muscolo come fanno le altre. Si chiama ATR-258, è svedese, anche se la Fase 2 clinica è appena partita a Copenaghen.
La differenza con i farmaci GLP-1 è radicale: questo non agisce sul cervello tagliando la fame, ma accende il muscolo scheletrico per fargli consumare di più.
EL MUNDO - Diario online líder de información en español [Unofficial]Los fármacos tipo Ozempic abren una nueva vía para prevenir el cáncer de mama
Italian News by RSSIl Fatto Quotidiano: “Corro verso la vastità che me ne frega dell’ossessione che hai per il mio corpo. Non c’è niente di innocente nel criticare la gente sui social”: Emma Marrone e la risposta a un leone da tastiera
Inutile. È tutto inutile. Anni spesi a cercare di non mettere i giudizi sul corpo altrui al centro delle discussioni, dei commenti social e sempre allo stesso punto stiamo. Anzi peggio: da che Ozempic e i suoi fratelli hanno preso a calci la faccenda della body positivity affrontare questo tema è ancora più complicato e basta aprire un social qualunque per vedere decine di utenti che discettano sui fisici delle star. Come fosse affare loro.
Un’utente ci ha provato con Emma Marrone, commentando il video dell’esibizione di lei a RTL Power Hits, domenica 31 maggio. “Ma mettersi a dieta no?”, ha scritto. E la cantante ha risposto e lo ha fatto in modo secco, giusto, diretto: “Sì Anna, mandami la tua! Intanto corro verso la vastità che me ne frega dell’ossessione che hai per il mio corpo“. “Oddio se non accetti nemmeno un’osservazione innocente, non stai messa bene!”, ha risposto l’utente (chissà se lo pensa davvero, che sia “un’affermazione innnocente”). E allora Emma: “Non c’è niente di innocente nel criticare la gente sui social“. Applausi. Per Emma, naturalmente.
L'articolo “Corro verso la vastità che me ne frega dell’ossessione che hai per il mio corpo. Non c’è niente di innocente nel criticare la gente sui social”: Emma Marrone e la risposta a un leone da tastiera proviene da Il Fatto Quotidiano.
I’m running towards the vastness that doesn’t care about your obsession with my body. There’s nothing innocent about criticizing people on social media. – Emma Marrone and a response to a keyboard lion.
It’s pointless. It’s all pointless. Years spent trying not to put people’s bodies at the center of discussions, social comments, and we always end up in the same place, worse even: since Ozempic and its siblings have kicked the body positivity issue, addressing this topic is even more complicated and simply opening any social media platform reveals dozens of users debating the physiques of celebrities. As if it were their business.
One user tried it with Emma Marrone, commenting on the video of her performance on RTL Power Hits, on May 31st. “But don’t you want to go on a diet?” she wrote. And the singer responded, and did so concisely, rightly, directly: “Yes Anna, send me yours! In the meantime, I’m running towards the vastness that I don’t care about your obsession with my body.” “Oh my god, if you don’t even accept a harmless observation, you’re not in a good position!” the user replied (who knows if they really think that, that it’s a “harmless statement”). And Emma: “There’s nothing harmless about criticizing people on social media.” Applause. For Emma, of course.
The article “I run towards the vastness that I don’t care about your obsession with my body. There’s nothing harmless about criticizing people on social media”: Emma Marrone and the response to a keyboard lion comes from Il Fatto Quotidiano.
“Corro verso la vastità che me ne frega dell’ossessione che hai per il mio corpo
La cantante ha replicato a chi le chiedeva se non fosse il caso di “mettersi a dieta”: “Non c’è niente di innocente nel criticare la gente sui social”. E il punto è proprio questo: i corpi non sono un referendum permanente
Dave J#Ozempic’s partially subsided by the #PharmaceuticalBenefitsScheme for blood glucose management and pre-surgery weight loss. #Wegovy—the same drug, #semaglutide, sold under a different name to treat #obesity and other conditions—currently isn’t, though it’s looking positive.
~65% of #Australia’s population could benefit from GLP-1 agonists, but the #PBS can’t possibly meet eligible demand. (1/2)
Re: https://social.chinwag.org/@abc_bot/116682082466028205 #auspol #health #medicine #diabetes #poverty
Unofficial ABC News Bot (@[email protected])
Ozempic-like drugs may improve kidney disease outcomes: study https://www.abc.net.au/news/health/2026-06-03/ozempic-style-drugs-improve-kidney-disease-outcomes-study/106743854 #LiverandKidneys #Pharmaceuticals #MedicalResearch #HeartDisease #Health
Popcorn PunchlinesMasters of the Universe (2026)
Interaksyon [Unofficial]Factbox: How to find and check an Ozempic batch number
LawrenceUn médecin m’avait déjà demandé si j’étais intéressé à prendre de l’Ozempic pour une meilleure gestion du diabète, après avoir vu les effets secondaires, plus aussi certain de vouloir l’essayer, surtout si je décidais de cesser le traitement. #Ozempic Reprise de poids, risque de pancréatite, nausées, diarrhée, constipation, etc. #diabète